Ironwood Pharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference

  Ironwood Pharmaceuticals to Present at Cowen and Company 34th Annual Health   Care Conference  Cowen and Company 34th Annual Healthcare Conference  Business Wire  CAMBRIDGE, Mass. -- February 24, 2014  Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 2014 Cowen and Company 34^th Annual Health Care Conference on Monday, March 3, 2014 at 3:30 p.m. Eastern Time at The Boston Marriott Copley Place.  A live webcast of Ironwood’s presentation will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwood’s website for 14 days following the conference.  About Ironwood Pharmaceuticals  Ironwood Pharmaceuticals (NASDAQ: IRWD) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our team to passionately pursue excellence. We discovered, developed and are commercializing linaclotide, which is approved in the United States and Europe. Our pipeline priorities include exploring further opportunities for linaclotide, as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to address patient needs across the upper and lower gastrointestinal tract. Ironwood was founded in 1998 and is headquartered in Cambridge, Mass. Connect with us at www.ironwoodpharma.com or on Twitter at www.twitter.com/ironwoodpharma; information that may be important to investors will be routinely posted in both these locations.  Contact:  Ironwood Pharmaceuticals, Inc. Media Contact Trista Morrison, 617-374-5095 Associate Director, Corporate Communications tmorrison@ironwoodpharma.com or Investor Contact Meredith Kaya, 617-374-5082 Director, Investor Relations mkaya@ironwoodpharma.com  
Press spacebar to pause and continue. Press esc to stop.